Atle Fund Management AB
Atle Fund Management AB reported 39 stocks worth $373M in its 13F filing for Q3 2026, filed Nov 12, 2026. Its largest holdings are LLY (9.7%), MRK (6.6%) and JNJ (6.5%). Compared with Q2 2026, the fund opened new positions in SMMT, CMPS and PVLA, added to LLY, JNJ and ABBV, trimmed MRK, RVMD and CVS and sold out of IONS, BCAX and CMPX.
Latest filing: what Atle Fund Management AB did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() LLY Eli Lilly & Co | $36.1M | 9.7% | 31K | +1,381 (+5%) | 8 of 8 | |
| 2 | ![]() MRK Merck & Co Inc | $24.6M | 6.6% | 169K | −20K (−11%) | 8 of 8 | |
| 3 | ![]() JNJ Johnson & Johnson | $24.2M | 6.5% | 91K | +5,962 (+7%) | 3 of 8 | |
| 4 | ![]() ABBV Abbvie Inc | $23.9M | 6.4% | 91K | +27K (+42%) | 8 of 8 | |
| 5 | ![]() TMO Thermo Fisher Scientific Inc | $23.2M | 6.2% | 34K | +6,551 (+24%) | 8 of 8 | |
| 6 | ![]() BIIB Biogen Inc | $16M | 4.3% | 71K | +8,174 (+13%) | 2 of 8 | |
| 7 | ![]() VRTX Vertex Pharmaceuticals I | $14.7M | 3.9% | 28K | +9,026 (+47%) | 8 of 8 | |
| 8 | ![]() RVMD Revolution Medicines Inc | $13.6M | 3.6% | 66K | −6,964 (−10%) | 8 of 8 | |
| 9 | ![]() ONC Beone Medicines Ltd | $13.1M | 3.5% | 36K | +499 (+1%) | 8 of 8 | |
| 10 | ![]() CVS Cvs Health Corp | $11.9M | 3.2% | 139K | −6,791 (−5%) | 4 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 12, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Atle Fund Management AB 13F FAQ
What does Atle Fund Management AB own?
Atle Fund Management AB reported 39 stocks worth $373M in its 13F filing for Q3 2026, filed Nov 12, 2026. Its largest holdings are LLY (9.7%), MRK (6.6%) and JNJ (6.5%). The table above lists every position in the filing (the top 10 without an account).
What did Atle Fund Management AB buy and sell in Q3 2026?
Compared with Q2 2026: 4 new positions, 18 added to, 15 trimmed and 4 sold out. New positions include SMMT, CMPS and PVLA. It sold all of IONS, BCAX and CMPX.
When will Atle Fund Management AB file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Atle Fund Management AB's portfolio worth?
The Q3 2026 filing reports $373M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.






















